Automated Suturing Devices Market Size & Share 2026-2035

Automated Suturing Devices Market Size

The global automated suturing devices market was valued at USD 628.4 million in 2025. The market is expected to grow from USD 669.6 million in 2026 to USD 1.2 billion in 2035, growing at a CAGR of 6.7% during the forecast period, according to the latest report published by Global Market Insights Inc.

The major players in the market are Johnson & Johnson MedTech, Boston Scientific, Medtronic, and LSI Solutions. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.

The market has increased from USD 521.4 million in 2022 to USD 589 million in 2024, with a historic growth rate of 6.3%. The market growth was driven by the growing adoption of automation in operating rooms, increasing demand for faster wound closure techniques, and growing demand in emerging markets.

Moreover, the increasing global volume of surgical procedures is a key driver for automated suturing devices, as healthcare systems aim to improve efficiency and reduce operation time. Growth in chronic diseases, aging populations, and elective surgeries has significantly raised procedural demand. Automated suturing devices help surgeons manage higher caseloads by enabling faster, more consistent wound closure while minimizing fatigue. Hospitals are increasingly adopting these solutions to optimize workflow, reduce human error, and enhance patient outcomes. This demand is particularly strong in high-volume surgical specialties such as cardiovascular, gastrointestinal, and orthopedic procedures.

Additionally, rapid advancements in robotic-assisted surgery are accelerating the adoption of automated suturing devices by enabling higher precision and control during complex procedures. Integration with robotic systems allows surgeons to perform delicate suturing tasks with enhanced dexterity, improved visualization, and minimal invasiveness. These technologies reduce variability in suturing quality and improve consistency across procedures. As hospitals increasingly invest in advanced surgical robotics, automated suturing solutions are becoming essential components of integrated surgical platforms, driving market growth.

Automated suturing devices are advanced surgical tools designed to assist or perform tissue stitching with minimal manual intervention, enhancing precision, consistency, and speed. They are widely used in minimally invasive and robotic-assisted procedures to improve surgical efficiency and patient outcomes.

Automated Suturing Devices Market Trends

Integration with robotic-assisted surgical systems, a shift toward minimally invasive procedures, rising adoption in ambulatory surgical centers, and advancements in smart and AI-enabled suturing technologies, among other trends, are driving the market growth.

• Automated suturing devices are increasingly being integrated into robotic-assisted platforms, enabling enhanced precision and control during complex procedures. This trend is improving surgical consistency, reducing manual errors, and driving adoption in advanced operating rooms, particularly in minimally invasive and high-risk surgeries.
• The growing preference for minimally invasive surgeries is significantly boosting demand for automated suturing devices. These tools support faster, more precise suturing in confined spaces, reducing complications, shortening recovery time, and improving patient outcomes, making them essential in laparoscopic and endoscopic procedures.
• Emerging innovations in AI and smart surgical tools are enabling automated suturing systems to provide real-time feedback, improve stitching accuracy, and assist surgeons in decision-making. This trend is enhancing procedural outcomes and supporting the evolution of intelligent surgical ecosystems.

Automated Suturing Devices Market Analysis

Based on product type, the automated suturing devices market is segmented into disposable and reusable. The disposable segment has asserted its dominance in the market by securing a significant market share of 64.5% in 2025 owing to increasing preference for single-use devices to reduce cross-contamination risks, stringent infection control protocols, and their ease of use in high-volume surgical settings. The segment is expected to exceed USD 820.7 million by 2035, growing at a CAGR of 7.3% during the forecast period.

• Disposable automated suturing devices are gaining strong traction due to their convenience, safety, and infection control benefits. These single-use devices eliminate the need for sterilization and reduce the risk of cross-contamination, making them ideal for high-volume surgical environments.
• Hospitals and ambulatory surgical centers increasingly prefer disposable options to streamline workflow and reduce turnaround time between procedures.
• Additionally, they minimize maintenance requirements and operational complexities. Their cost-effectiveness in the long term, especially in settings with high patient throughput, is driving adoption.
• The reusable segment held a revenue of USD 223.2 million in 2025. Reusable automated suturing devices are widely used in established healthcare facilities where cost optimization over multiple procedures is prioritized.
• These devices are designed for durability and repeated use, requiring proper sterilization and maintenance between procedures. They are often preferred in large hospitals with advanced sterilization infrastructure.

Based on application, the automated suturing devices market is classified into gastrointestinal surgery, cardiovascular surgery, gynecological surgery, orthopedic surgery, ophthalmic surgery, and other surgical applications. The gastrointestinal surgery segment held a leading revenue share of 32.6% in 2025.

• Automated suturing devices play a crucial role in gastrointestinal surgeries, where precision and speed are essential for procedures involving the digestive tract.
• These devices are particularly useful in minimally invasive laparoscopic surgeries, enabling consistent and secure suturing in confined spaces. Their use reduces surgical time and improves patient recovery outcomes by minimizing complications such as leaks or improper closure.
• Further, with the rising prevalence of gastrointestinal disorders and increasing adoption of advanced surgical techniques, demand for automated suturing solutions continues to grow in this segment.
• The cardiovascular surgery segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.9% over the forecast period. In cardiovascular surgery, automated suturing devices are used to handle delicate and complex procedures involving blood vessels and cardiac tissues.
• In addition, these surgeries require extremely precise suturing to ensure proper healing and avoid complications. Automated solutions help reduce variability and enhance consistency, especially in minimally invasive cardiac procedures.
• Moreover, their ability to perform secure suturing quickly is critical in reducing operative time and improving patient survival rates.
• The gynecological surgery segment accounted for a revenue share of 17.3% in 2025. Gynecological procedures, including hysterectomies and pelvic reconstructive surgeries, are increasingly utilizing automated suturing devices to improve efficiency and patient outcomes.
• Additionally, these devices support minimally invasive approaches, enabling precise suturing in confined anatomical spaces. Their use reduces surgical fatigue and enhances accuracy, particularly in laparoscopic and robotic-assisted procedures.
• Furthermore, growing awareness of women’s health and increasing demand for advanced surgical techniques are driving adoption in this segment.

Based on end use, the automated suturing devices market is classified into hospitals, specialty clinics, and ambulatory surgery centers. The hospitals segment dominated the market with a revenue share of 62.9% in 2025 and is expected to reach USD 743.6 million within the forecast period.

• Hospitals represent the largest end-use segment for automated suturing devices due to their high volume of surgical procedures and access to advanced medical infrastructure. They are early adopters of innovative surgical technologies, including robotic-assisted systems.
• Additionally, automated suturing devices help hospitals improve operational efficiency, reduce procedure times, and enhance patient outcomes. Large hospitals also invest in staff training and integrated surgical platforms, further supporting adoption.
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 7.3% over the forecast period. Ambulatory surgical centers (ASCs) are rapidly adopting automated suturing devices to support same-day procedures and high patient turnover. These facilities prioritize efficiency, cost-effectiveness, and quick recovery times.
• Further, automated suturing enables faster procedures and consistent outcomes, aligning with the operational goals of ASCs. The growing trend toward outpatient care and minimally invasive surgeries is significantly boosting demand in this segment.
• Moreover, compact, easy-to-use devices are particularly attractive for ASCs, as they help streamline workflows without requiring extensive infrastructure, making them ideal for modern outpatient surgical environments.

North America Automated Suturing Devices Market

North America dominated the market with the highest market share of 33.4% in 2025.

• The U.S. automated suturing devices industry was valued at USD 161.8 million and USD 170.7 million in 2022 and 2023, respectively. The market size reached USD 191.6 million in 2025, growing from USD 180.7 million in 2024, and is anticipated to grow at a CAGR of 6.1% from 2026 to 2035.
• North America represents a leading market for automated suturing devices due to its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and early integration of robotic-assisted surgery.
• The region benefits from the strong presence of major medical device companies, continuous technological innovation, and well-established reimbursement systems. High surgical volumes driven by chronic diseases and an aging population further support market growth.
• Additionally, strong focus on clinical research, surgeon training, and adoption of next-generation surgical platforms continues to accelerate demand for automated suturing devices across the region.

Europe Automated Suturing Devices Market

Europe market accounted for USD 172.9 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe is experiencing steady growth in the automated suturing devices industry, driven by increasing demand for minimally invasive procedures and rising healthcare modernization efforts.
• Countries such as Germany, the UK, and France are key contributors, supported by well-developed healthcare systems and strong regulatory frameworks. The region is focused on improving surgical outcomes and reducing hospital stays, encouraging adoption of advanced suturing technologies.
• Additionally, growing investments in robotic surgery and medical innovation are supporting market expansion.

Asia Pacific Automated Suturing Devices Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7.9% during the analysis timeframe.

• Asia Pacific is witnessing rapid growth in the automated suturing devices industry due to expanding healthcare infrastructure, rising medical tourism, and increasing surgical volumes.
• Countries such as China, India, and Japan are driving demand, supported by large patient populations and growing awareness of advanced surgical techniques.
• Further, the region is also benefiting from rising healthcare investments and government initiatives aimed at improving access to quality care. Additionally, adoption of minimally invasive and robotic-assisted procedures is gradually increasing, particularly in urban healthcare centers.

Latin America Automated Suturing Devices Market

The Latin America automated suturing devices industry is experiencing robust growth over the analysis timeframe.

• Latin America is emerging as a growing market for automated suturing devices, supported by improving healthcare infrastructure and increasing access to surgical care.
• Countries such as Brazil and Mexico are leading adoption, driven by a rising burden of chronic diseases and trauma cases.
• The demand for minimally invasive procedures is gradually increasing, encouraging healthcare providers to adopt advanced surgical technologies.

Middle East & Africa Automated Suturing Devices Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The Middle East & Africa region is experiencing gradual growth in the automated suturing devices industry, driven by improving healthcare infrastructure and increasing investments in advanced medical technologies.
• Countries in the Middle East, such as Saudi Arabia and the UAE, are leading adoption due to strong government support and modernization of healthcare systems.
• Further, rising prevalence of chronic diseases and trauma cases is increasing surgical demand. A growing focus on medical tourism and the expansion of private healthcare facilities are expected to support future market growth across the region.

Automated Suturing Devices Market Share

The automated suturing devices industry is concentrated, led by a mix of large multinational medical device companies and specialized niche players. Established firms such as Johnson & Johnson MedTech, Medtronic, and Boston Scientific dominate through strong brand recognition, extensive surgical portfolios, and global distribution networks. These companies leverage their expertise in minimally invasive and robotic-assisted surgery to integrate suturing technologies into broader surgical ecosystems, creating high entry barriers for new entrants.

Competition is driven primarily by technological innovation, product reliability, ease of use, and compatibility with minimally invasive procedures. Key players focus on enhancing precision, reducing operative time, and improving patient outcomes to differentiate their offerings. Continuous investments in R&D and clinical validation are critical strategies to maintain competitiveness.

At the same time, smaller companies like LSI Solutions compete by targeting niche segments with specialized, cost-effective, and disposable suturing devices. These players often emphasize flexibility, customization, and faster innovation cycles, allowing them to address unmet clinical needs. The market is also witnessing increasing collaboration between device manufacturers and healthcare providers to support training and adoption.

Automated Suturing Devices Market Companies

A few of the prominent players operating in the automated suturing devices industry include:

• Anchora Medical
• Boston Scientific
• ErgoSuture
• Johnson & Johnson MedTech
• LSI Solutions
• Medtronic
• Mellon Medical
• Suturion
• Johnson & Johnson MedTech

Focuses on expanding advanced surgical solutions by integrating automated suturing with robotic platforms, investing heavily in R&D, strengthening surgeon training programs, and leveraging global distribution to drive adoption across hospitals.

• Boston Scientific

Prioritizes minimally invasive innovation through targeted product development and acquisitions, enhances physician education initiatives, strengthens presence in outpatient settings, and builds strategic collaborations to broaden procedural applications and market reach.

The automated suturing devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Disposable
• Reusable

Market, By Application

• Gastrointestinal surgery
• Cardiovascular surgery
• Gynecological surgery
• Orthopedic surgery
• Ophthalmic surgery
• Other surgical applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE